NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule
EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (
Stay updated with breaking news from Inducement Grant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (
Viridian Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced the appointment of...
REDWOOD CITY, Calif., Jan. 24, 2024 -- Rezolute, Inc. , a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare...
Awards Mr. Freedberg an Inducement Grant in accordance with Nasdaq Listing Rule 5635NEW HAVEN, Conn., Jan. 16, 2024 -- Arvinas, Inc. , a clinical-stage biotechnology company creating a new class of...
- VRDN-001 topline clinical results for THRIVE and THRIVE-2 on track for mid-2024 and year-end 2024 in patients with active and chronic thyroid eye disease , respectively - - Subcutaneous VRDN-003...